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Abstract
Introduction: It is unclear why cerebral small vessel disease (SVD) leads to lacunar stroke in some and to non–lobar
intracerebral hemorrhage (ICH) in others. We investigated differences in MRI markers of SVD in patients with lacunar
stroke or non–lobar ICH.
Patients and methods: We included patients from two prospective cohort studies with either lacunar stroke (RUN
DMC) or non–lobar ICH (FETCH). Differences in SVD markers (white matter hyperintensities [WMH], lacunes, cere-
bral microbleeds [CMB]) between groups were investigated with univariable tests; multivariable logistic regression
analysis, adjusted for age, sex, and vascular risk factors; spatial correlation analysis and voxel–wise lesion symptom
mapping.
Results: We included 82 patients with lacunar stroke (median age 63, IQR 57–72) and 54 with non-lobar ICH (66,
59–75). WMH volumes and distribution were not different between groups. Lacunes were more frequent in patients
with a lacunar stroke (44% vs. 17%, adjusted odds ratio [aOR] 5.69, 95% CI [1.66–22.75]) compared to patients with a
non–lobar ICH. CMB were more frequent in patients with a non–lobar ICH (71% vs. 23%, aOR for lacunar stroke vs
non–lobar ICH 0.08 95% CI [0.02–0.26]), and more often located in non–lobar regions compared to CMB in lacunar
stroke.
Discussion: Although we obserd different types of MRI markers of SVD within the same patient, ischemic markers of
SVD were more frequent in the ischemic type of lacunar stroke, and hemorrhagic markers were more prevalent in the
hemorrhagic phenotype of non-lobar ICH.
Conclusion: There are differences between MRI markers of SVD between patients with a lacunar stroke and those
with a non-lobar ICH.
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Cerebral small vessel disease (SVD) is the presumed
underlying cause of up to 25% of all ischemic strokes
and 85% of intracerebral hemorrhages (ICH).1,2 SVD
refers to pathological changes of the small vessels of the
brain, and can manifest itself in hereditary and sporad-
ic forms.3 Cerebral amyloid angiopathy (CAA) primar-
ily affects the superficial perforating arteries, whereas
the non–CAA form of SVD mainly affects the deep
perforating arteries.3
It is still poorly understood why some patients with
the similar form of non-CAA sporadic SVD present
with an ischemic lacunar stroke whereas others present
with a non-lobar ICH.4,5
Consequences of SVD can be visualized by its
markers on magnetic resonance imaging (MRI),
including white matter hyperintensities (WMH),
lacunes, and cerebral microbleeds (CMB).6
Previously, periventricular WMH burden has been
associated with a lacunar stroke, whereas presence of
CMB was associated with a non–lobar ICH.7 This
study, however, did not investigate differences in spa-
tial distribution patterns of SVD markers on MRI
between groups, which could be essential for under-
standing the clinical course of SVD. Our results may
potentially identify MRI markers of SVD that differ-
entially predispose to either ischemia or hemorrhage,
that in time may have implications for secondary pre-
ventive treatment.
Therefore, we aimed to investigate whether presence
and spatial distribution of WMH, lacunes, and CMB
on MRI differ between patients with a lacunar stroke
and those with a non–lobar ICH.
Patients and methods
Study population
We identified patients from two prospective cohort
studies; individuals with a lacunar stroke from the
Radboud University Nijmegen Diffusion tensor and
MRI Cohort (RUN DMC) and with a non–lobar
ICH from the Finding the ETiology in spontaneous
Cerebral Hemorrhage (FETCH) study. The Medical
Review Ethics Committee Region Arnhem-Nijmegen
approved the RUN DMC study and the medical
ethics committee of the UMCU approved the
FETCH study. All patients gave written informed
consent.
The RUN DMC is a single–center, prospective,
cohort study which investigated 503 non–demented
elderly, aged between 50–85 years old, with evidence
of SVD on MRI (WMH or lacunes).8 All participants
underwent a structural interview, clinical assessment,
and a 1.5 Tesla (T) MRI protocol. In this study, we
included patients with lacunar stroke (ischemic stroke
or transient ischemic attack [TIA]) in their medical his-
tory (Supplementary Figure 1). Patients were excluded
if there was evidence for any other presumed cause of
ischemia in their medical history (i.e. including large
artery disease, cardioembolic source, or embolic
stroke or TIA of undetermined source) or if they had
a history of ICH. If neuroimaging was available in the
patients’ file, subcortical MRI lesions consistent with
clinical symptoms were used as confirmation that clin-
ical symptoms were caused by lacunar infarction.
The FETCH study is a multi–center, prospective,
cohort study amongst 204 adults that presented with
a symptomatic spontaneous ICH confirmed by com-
puted tomography (CT).9 Patients underwent 3T
and/or 7T MRI in one of three participating centers
(University Medical Centers of Utrecht, Leiden or
Nijmegen). Secondary causes were excluded by CT
angiography in all and by digital subtraction angio-
gram if clinically indicated. For this study, we included
patients of 50 years and older with a 3T MRI and ICH
in the basal ganglia, thalamus, brainstem or
cerebellum.
Demographics and vascular risk factors were
assessed and defined as follows: age at the time of the
MRI; sex; hypertension as the use of antihypertensive
medication, systolic blood pressure 140mm Hg, or
diastolic blood pressure 90mm Hg, based on the
average of three (RUN DMC) or two (FETCH; in
medical history before the ICH) blood pressure meas-
urements or left ventricular hypertrophy on ECG; dia-
betes mellitus as the usage of oral antidiabetics and/or
insulin (RUN DMC) or as reported in medical history
and/or two fasting glucose measurements of >7mmol/
l (FETCH); history of smoking as ever or never
smoked; alcohol overuse as alcohol use 300 g per
week; and body mass index (BMI) by dividing the
weight in kilograms by the height in meters squared.
MRI markers of SVD
MRI data. In the RUN DMC study, participants were
scanned using one single 1.5 T MRI scanner (Siemens
Healthineers, Erlangen, Germany), whereas the
FETCH study used three different 3T MRI scanners
(Siemens Healthineers, Erlangen, Germany; Phillips
Healthcare, Best, The Netherlands). For a detailed
overview of the MRI sequences of both studies (and
participating centers) please see Supplementary Table
1. We rated WMH, lacunes, and CMB in accordance
with the STandards for ReportIng Vascular ChangEs
on neuroimaging (STRIVE) criteria.6
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White matter hyperintensities. WMH segmentation on
FLAIR sequences was performed as previously pub-
lished for the RUN DMC dataset,10 and segmented
in the ICH-free hemisphere for the FETCH dataset,
using intensity–based thresholding in MRIcro
(https://www.mricro.com), and subsequent manual
adjustment by one of two trained raters. The ICH-
free hemisphere was used because WMH cannot be
distinguished from perihematomal edema, if located
in neighboring areas. WMH volumes were expressed
as a percentage of intracranial volume in both datasets.
WMH masks were normalized to Montreal
Neurological Institute (MNI) 152 standard space
using the Functional Magnetic Resonance Imaging of
the Brain Software Library Software Library (FSL).11
First, we skull–stripped each image using the FSL
Brain Extraction Tool (BET). Second, we registered
FLAIR to T1 images using the FSL Linear Image reg-
istration tool (FLIRT; correlation ratio). Third, we
used FLIRT and the FSL Non–linear Registration
Tool (FNIRT) to register T1 images to the MNI tem-
plate. Lastly, we applied the resulting transformation
matrices to the WMH masks. We generated bilateral
masks in the FETCH dataset by inverting WMH
masks and registering them to the contralateral hemi-
sphere. All registration steps were checked visually. We
generated WMH frequency maps displaying the pro-
portion of participants with WMH in any given voxel
for visualization purposes.
Lacunes
Lacunes were assessed by location by one of two
trained raters, and categorized as lobar (centrum semi-
ovale, frontal, parietal, insular/subinsular, temporal,
occipital) or non–lobar (basal ganglia, thalamus, inter-
nal and external capsule, brain stem, cerebellum).12
Agreement with a second rater in random subsamples
was good (Cohen’s kappa> 0.7 in both datasets). Final
decisions were made in consensus involving more expe-
rienced raters (FEdL, MD). All lacunes were manually
segmented on T1 images, and normalized to MNI 152
standard space via T1 images using the registration
tools ‘FLIRT’ and ‘FNIRT’ from FSL.11 We created
spherical maps, with each sphere representing a single
lacune, to visualize the distribution of lacunes over
lobar and non–lobar regions.
Microbleeds
CMB were assessed by one trained rater (RUN DMC)
or screened by a semiautomatic method after which
true CMB were selected by a human rater
(FETCH).13 Location of CMB was determined by
using the Microbleed Anatomical Rating Scale
(MARS),14 categorizing distribution as lobar (frontal,
parietal, temporal, occipital, insula) and non–lobar
(basal ganglia, thalamus, internal and external capsule,
corpus callosum, deep and periventricular white
matter, brain stem, cerebellum). A second rater
assessed microbleeds in a random subsample
(Cohen’s kappa ¼ 0.70 in both datasets), indicating
good inter–rater agreement. Final consensus was
reached during meetings with experienced clinical neu-
rologists (FEdL, FHBMS). After manual segmenta-
tion, CMB lesion masks were normalized to MNI 152
standard space via T1 images, and spherical maps were
created with each sphere representing one single CMB.
Statistical data analysis
All analyses were performed using R (version 3.5.3;
https://www.R–project.org). We considered two–
tailed p values <0.05 to be statistically significant.
Demographics, vascular risk factors, and MRI markers
of SVD were compared between patients with a lacunar
stroke and a non–lobar ICH using univariable tests
(independent sample t test, Chi–squared test, and
Mann–Whitney U test where appropriate). We investi-
gated associations of SVD MRI markers with either of
the two stroke types using an age– and sex adjusted
multivariable logistic regression model including vascu-
lar risk factors that were significant in univariate tests
(glm R package). Additionally, for patients with 1
lacune or 1 CMB, we compared the percentage of
lobar vs non–lobar lesions using non–parametric uni-
variate tests (Mann–Whitney U tests).
To compare differences in WMH distribution
between groups, we performed a spatial correlation
analysis and voxel–wise lesion symptom mapping
(VLSM). For each voxel in MNI 152 standard space,
the lesion frequency was compared between groups
using linear correlation, where a correlation coefficient
of 1 indicates an identical lesion distribution.
Furthermore, we investigated whether a voxel in stan-
dard space more frequently was a WMH (yes/no) in
lacunar stroke or non–lobar ICH using VLSM in in
NiiStat (https://www.nitrc.org/projects/niistat/). We
only included voxels that were damaged in at least
4% of the patients,15 and adjusted analysis for age
and total WMH volume. Permutation–based thresh-
olding was used to control for family–wise error
(FWE) at 5% (p< .05, two–tailed, 5000 Freedman–
Lane permutations).
Results
In total, we included 82 patients with a lacunar stroke
(63% males, median age 63 years, interquartile range
[IQR] 57–72, 45 ischemic stroke and 37 TIA).
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Additionally, 54 patients with a non–lobar ICH were
included (74% males, median age 66 years, IQR 59–75;
Supplementary Figure 1, 35 deep and 19 infratento-
rial). Eight of 54 (15%) patients had more than one
ICH. The median stroke–MRI interval for patients
with lacunar stroke was 198 days (IQR 95–630), and
for patients with non–lobar ICH 13.5 days (6–38).
Patient characteristics are summarized in Table 1.
Patients with lacunar stroke more frequently had
hypertension and a history of smoking than those
with non–lobar ICH (Table 1).
MRI markers of SVD
White matter hyperintensities. The median WMH volume
was similar in patients with a lacunar stroke (0.3mL
IQR [0.1–0.8] and a non–lobar ICH (0.4mL [0.2–0.9],
p¼.227). WMH were most prevalent in the periventric-
ular and frontal white matter in both groups (Figure 1).
The spatial correlation analysis demonstrated that the
colocalization of WMH between groups was strong
(R2¼0.71; p< 2.2e–16). VSLM analysis, adjusted for
age, sex, and normalized WMH volume, showed a
comparable distribution of WMH as there were no
major clusters of voxels with WMH associated with
either a lacunar stroke or a non–lobar ICH
(Supplementary Figure 2).
Lacunes. Of 82 patients with a lacunar stroke, 36 (44%)
had at least one lacune, in comparison with 9 of 54
patients with a non–lobar ICH (17%, p¼.001).
Presence of lacunes was significantly associated with
a lacunar stroke after adjustment for age, sex, history
of hypertension and smoking (aOR 5.69, 95% CI 1.66–
22.75, Table 1). In patients with a lacunar stroke, 51 of
70 lacunes (73%) were in lobar regions, and 8 of 10
(80%) in patients with a non–lobar ICH (p¼ 0.423,
Table 2, Figure 2).
Cerebral microbleeds. Of the patients with a lacunar
stroke, 19 (23%) had CMB, in comparison with 35 of
patients with a non–lobar ICH (67%, p< .001).
Presence of CMB was significantly associated with a
non–lobar ICH after adjustment for age, sex, history
of hypertension and smoking (aOR for lacunar stroke
vs non–lobar ICH 0.08, 95% CI 0.02–0.26). In patients
with a lacunar stroke, 59 of 76 CMB (78%) were in
lobar regions, and in patients with a non–lobar ICH
162 of 302 CMB (54%) were in lobar regions (p¼.006,
Table 2, Figure 3).
Discussion
Patients with a lacunar stroke and patients with a non–
lobar ICH have similar volume and spatial distribution
of WMH. Lacunes were more frequent in patients with
a lacunar stroke, and CMB were more prevalent in
patients with a non–lobar ICH. Spatial distribution
of lacunes was similar in patients with a lacunar
stroke and a non–lobar ICH, but CMB were more








OR (95% CI) p-Value
Multivariable
OR (95% CI) p-Value
Demographics
Age at MRI, years,
median [IQR]
63 [57–72] 66 [59–75] 2.6 (–1.1; 6.6) .198 0.95 (0.89; 1.01) .092
Male sex, N (%) 52 (63%) 39 (73%) 0.7 (0.3; 1.5) .286 3.52 (1.26; 10.35) .018
Vascular risk factors
Hypertension, N (%) 66 (80%) 32 (60%) 2.8 (1.3; 6.2) .012 6.72 (2.11; 24.76) .002
Diabetes mellitus, N (%) 15 (18%) 8 (15%) 1.3 (0.5; 3.4) .597
History of smoking, N (%) 69 (84%) 30 (57%) 4.1 (1.8; 9.3) <.001 3.38 (1.13; 10.71) .032
Alcohol overuse, N (%) 27 (36%) 15 (29%) 1.4 (0.6; 3.0) .429
BMI, kg/m2, mean (SD) 27 4 25 5 –1.2 (–2.8; 0.4) .111
MRI markers of SVD
WMH volume, % ICV,
median [IQR]
0.3 [0.1–0.8] 0.4 [0.2–0.9] 0.07 (–0.05; 0.2) .227
Presence of lacunes, N (%) 36 (44%) 9 (17%) 3.7 (1.7–9.1) .001 5.69 (1.66; 22.75) .008
Presence of CMB, N (%) 19 (23%) 35 (67%) 0.2 (0.1; 0.3) <.001 0.08 (0.02; 0.26) <.001
ICV, mL, mean (SD) 1484 (146) 1476 (166) –7.7 (–67; 52) .969
ICH: intracerebral hemorrhage; CI: confidence interval; OR: odds ratio; IQR: interquartile range; SD: standard deviation; BMI: body mass index; WMH:
white matter hyperintensities; CMB: cerebral microbleeds; ICV: intracranial volume. Values represent median [IQR], N (%), or mean (SD). Information
on history of smoking was missing in 1 (1%), alcohol overuse in 8 (6%), WMH volumes in 9 (7%), presence of lacunes in 2 (1%), CMB presence in 3
(2%), and ICV in 5 (4%) patients. Multivariable odd ratios and corresponding 95% confidence intervals represent results from the logistic regression
analysis for lacunar stroke versus non-lobar intracerebral hemorrhage (ICH) adjusted for age, sex, and vascular risk factors significant in univariate
analysis.
p-values (the significant ones are printed in bold).
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often non–lobar in patients with a non–lobar ICH
compared to CMB in patients with a lacunar stroke.
In contrast to our findings of a similar burden and
distribution of WMH, in a previous study severe con-
fluent periventricular WMH were found to be associ-
ated with a lacunar stroke compared to a non–lobar
ICH.7 However, these findings were based on visual
ratings of WMH, whereas in our study we made use
of quantitative measures and a voxel–based approach.
In our study, WMH were most frequent in periventric-
ular areas, around the anterior and posterior horns of
the lateral ventricles (Figure 1). The periventricular
regions are known to be specifically vulnerable to ische-
mia,16,17 as they are located at the arterial end zone (the
very ends of arterial territories) including the junction
of the deep and superficial perforating arteries.18,19
Previous data demonstrated a strong inverse voxel–
wise correlation between resting–state perfusion and
WMH frequency, in individuals with CAA, mild
cognitive impairment, Alzheimer’s disease and healthy
controls,20 indicating that across these different popu-
lations, WMH are most frequent in regions with rela-
tively lower cerebral perfusion. However, this needs to
be confirmed in prospective studies.
Even though far more frequent in lacunar stroke,
patients with a non–lobar ICH also had lacunes.
Alterations in cerebral hemodynamics, blood–brain
barrier permeability, release of inflammatory cyto-
kines, and blood pressure after an ICH may give rise
to a higher frequency of ischemic lesions.21 Likewise,
the incidence of CMB has been reported to be relatively
high after ischemic stroke.22 In addition to a similar
distribution of WMH, patients with a lacunar stroke
or a non–lobar ICH showed a large similarity in the
distribution of lacunes, suggesting a common patho-
physiological mechanism. This could be explained by
previous studies within genetically defined SVD, where
incident lacunes were found to predominantly occur
within the orientation of perforating arteries,23 and
the majority were localized at the edges of WMH.24
Another study demonstrated that lobar lacunes were
in contact with WMH in 80% of the cases and were
highly correlated with WMH volume, suggesting a
common origin.12 This might explain the he high pro-
portion of lobar lacunes found in our study, as WMH
are predominantly located in lobar white matter
regions, such as the centrum semiovale.
In contrast, CMB were more often lobar in patients
with a lacunar stroke compared to patients with a non–
lobar ICH. The high proportion of CMB in lobar brain
regions in subcortical SVD remains unexplained. We
are not able to fully exclude the possibility that CAA
might have contributed to the high proportion of lobar
CMB. Another study found evidence of moderate to
Figure 1. Distribution of white matter hyperintensities in patients with lacunar stroke or non–lobar intracerebral hemorrhage.
Frequency maps of white matter hyperintensities (WMH) superimposed on a MNI–152 0.5mm template, where each voxel
represents the percentage of individuals with a WMH in that voxel, as indicated by color–coded bars.
Table 2. Lesion counts by lobar and non-lobar brain regions in
patients with lacunar stroke or non-lobar intracerebral hemor-
rhage, with at least one lacune or cerebral microbleed.
Lacunar stroke Non-lobar ICH p-Value
Lacunes, N
Total 70 10
Lobar 51 (73%) 8 (80%) .423
Non-Lobar 19 (27%) 2 (20%) .206
CMB, N
Total 76 302
Lobar 59 (78%) 162 (54%) .006
Non-Lobar 17 (22%) 140 (46%) .008
ICH: intracerebral hemorrhage; CMB: cerebral microbleeds. Values
represent N (%). Lesion counts were compared between groups using
univariate Mann–Whitney U tests.
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severe CAA in around 6 of 48 (13%) participants with
non-lobar ICH (i.e. arteriosclerotic subcortical small
vessel disease).25 Furthermore, deep CMB were found
to be mainly associated with arteriosclerotic small
vessel disease, whereas both CAA and arteriosclerotic
small vessel disease contributed to the risk of lobar
CMB.26 Also, cerebellar hemorrhages might be due to
CAA if located in superficial regions.27 Collectively,
these results suggest that arteriosclerotic SVD and
CAA often co-exist, possibly resulting in a higher rate
of lobar CMB.
SVD can manifest itself as ischemic or hemorrhagic
disease, between which many risk factors are shared. If
we gain more insight into the pathophysiological
mechanisms that determine whether someone is more
prone to ischemic or hemorrhagic disease, this could
inform treatment decisions. In clinical practice, antipla-
telets are prescribed in patients with a lacunar stroke
but not after a non–lobar ICH, as antiplatelet therapy
was considered to increase the risk of ICH.28 However,
the recently completed RESTART clinical trial found
survivors of antithrombotic–associated ICH to have
fewer recurrences of ICH when antiplatelet therapy
was restarted compared to patients in whom antiplate-
let therapy was avoided.29 In addition, in contrast with
previous suggestions, cumulative evidence suggests that
presence of CMB should not be a reason to refrain
from antiplatelet therapy. A recent pooled analysis of
Figure 3. Distribution of cerebral microbleeds in patients with lacunar stroke or non–lobar intracerebral hemorrhage. Spherical
maps of cerebral microbleeds superimposed on a MNI–152 0.5mm template with each sphere indicating a single microbleed,
colour–coding represents lobar (orange) or non–lobar (red) locations.
Figure 2. Distribution of lacunes in patients with lacunar stroke or non–lobar intracerebral hemorrhage. Spherical maps of lacunes
superimposed on a MNI–152 0.5mm template with each sphere indicating a single lacune, colour–coding represents lobar (light blue)
or non–lobar (dark blue) locations.
6 European Stroke Journal 0(0)
individual patient data of patients with ischemia stroke
or TIA, showed that although presence of CMB
enhance the risk of ICH to a larger extent than that
of ischemic stroke, the absolute risk of ischemic stroke
in these patients is higher than the absolute risk of
ICH.30
Strengths of our study are the use of two prospec-
tively collected cohorts, the meticulous phenotyping,
and the combination of multiple statistical approaches,
including hypothesis–free voxel–based methods. Our
study also has limitations. First, as the two etiologies
originated from different studies, this might have led to
a systematic bias. For example, patients with a lacunar
stroke had a 1.5 T MRI, which may have led to under-
estimation of SVD burden.31Although the impact of
MRI field strength on WMH volume measurements
besides the expected improved resolution is still
unclear, a previous study in patients with multiple scle-
rosis demonstrated a 10% higher mean WMH volume
using 3T MRI versus 1.5 T MRI.32 Although there are
no studies investigating the variability of lacunes
according to MRI field strength, more CMB are
found at higher MRI field strengths.33 For instance, a
previous study in 25 patients with multiple sclerosis, 53
CMB were found using 3T MRI compared to 41 CMB
using 1.5 T MRI.34 Although the number of CMB
increases with field strength and resolution,31 the detec-
tion of whether any CMB are present or not, generally
remains consistent across different field strengths.
Overall, the severity of MRI markers of SVD might
have been underestimated on 1.5 T MRI scans. In addi-
tion, different blood-sensitive MRI sequences were
used (SWI or T2*–weighted imaging), which also
affects the number of CMB detected.35 Moreover, the
timing of the MRI was different between datasets.
Whereas FETCH patients were scanned in the acute
phase, MRI was performed in the chronic phase in
RUN DMC. Furthermore, differences in patient selec-
tion could have influenced our results. In the RUN
DMC study, patients were selected based on the pres-
ence of MRI markers of SVD, which might have
resulted in an overestimation of the prevalence of vas-
cular risk factors and neuroimaging markers. Although
both studies had a history of hypertension or hyperten-
sive treatment as part of their definition, diagnosis of
hypertension on the basis of blood pressure measure-
ments slightly differed between studies. In the non-
lobar ICH group this relied upon two independent
blood pressure measurements (systolic blood pressure
140mm Hg or diastolic blood pressure 90mm Hg)
reported in the medical history and did not include
data obtained during clinical admission. Therefore,
individuals in whom hypertension was discovered
during follow up after the ICH, were not included in
this definition. This may in part explain the lower
prevalence of hypertension in the group of non-lobar
ICH. Hypertension in the RUN DMC was based on
blood pressure measurements (systolic blood pressure
140mm Hg or diastolic blood pressure 90mm Hg)
at the time of inclusion. Furthermore, the finding that
there were no differences in the prevalence of diabetes
mellitus between groups might be due to the fact that
the RUN DMC did not include fasting glucose meas-
urements obtained during clinical admission, as we
know from previous studies that diabetes mellitus is
strongly associated with lacunar stroke compared to
ICH. Second, the sample size was relatively small.
Third, more severe ICHs are often fatal, and therefore
less likely to be investigated by MRI, which may have
resulted in an underestimation of burden of SVD
markers on MRI. Fourth, we did not investigate the
full spectrum of MRI markers of SVD. Future studies
should investigate the role of other MRI markers of
SVD, such as perivascular spaces or cortical microin-
farcts, in differentiating patients with non-lobar ICH
or lacunar infarcts.
In conclusion, SVD in patients with lacunar stroke
and non–lobar ICH cannot be distinguished by WMH
burden or distribution. Patients presenting with the
ischemic phenotype of lacunar stroke more often had
lacunes, whereas patients with the hemorrhagic pheno-
type of non–lobar ICH more frequently had CMB,
which were more often non–lobar than CMB in
patients with lacunar stroke. Future longitudinal stud-
ies in early disease stages should address the temporal
order and location of the occurrence of ischemic and
hemorrhagic lesions to elucidate the mechanisms
through which SVD causes different lesion types.
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